Continued Care is the clinical successor to the Metabolic Rebuild — the 5-month structured program where our partnership begins.
The clinical relationship that continues
Meaningful metabolic and hormonal change creates a new phase of care: protecting what you have built as your physiology continues to adapt.
The provider who built your plan stays your provider. The monitoring, the messaging access, and the clinical relationship do not reset when the Metabolic Rebuild ends. What changes is the cadence — calibrated to where your physiology is now.
Metabolic and hormonal shifts do not resolve on a fixed timeline. As your weight trends toward goal, your medications require adjustment, and your hormonal landscape stabilizes, the clinical relationship extends to match.
Two tiers of Continued Care:
Active Care — for patients whose physiology is still in motion. Same clinical rigor and oversight as the Rebuild.
Steady Care — for patients who have reached clinical stability. Long-term metabolic and hormonal stewardship at a lighter cadence.
Your provider guides the transition based on your progress and the complexity of your trajectory.
Why metabolic and hormonal care does not end at five months
Three clinical realities drive the transition from the Metabolic Rebuild into Continued Care.
The weight-defense response persists.
Your body’s biological resistance to sustained weight loss remains active for 12 to 24 months after meaningful loss occurs. During this window, your metabolic results either become durable or they quietly reverse as the body attempts to return to its previous set point. Continued clinical oversight — not willpower — determines which outcome prevails.
Chronic metabolic conditions require longitudinal management.
Most patients in this practice carry comorbid conditions that do not resolve in four months: insulin resistance, elevated cholesterol, high blood pressure, hypothyroidism. The Metabolic Rebuild addresses the acute picture. Continued care manages the chronic one.
Hormonal care is ongoing by nature.
Bioidentical hormone replacement therapy (BHRT) is durable, ongoing care. It requires ongoing prescribing, lab monitoring, and formulation adjustments as you move through perimenopause, menopause, and beyond. The provider who mapped your physiology is the one who monitors its evolution; that continuity is a clinical standard, not a convenience.
The clinical architecture continues
Clinical Partnership & Access
Your one dedicated provider stays with you. Biweekly visits during the Metabolic Rebuild step down to bimonthly in Active Care, then to every four months in Steady Care — but the clinical relationship does not change shape. Secure messaging access continues with a 48-hour business-day response. Open office hours remain on the calendar weekly. The clinical record holds your full metabolic and hormonal history from week one of the Metabolic Rebuild forward — every lab, every medication adjustment, every protocol change. The relationship is the infrastructure that makes everything else durable.
Clinical Monitoring Kit
The same clinical-grade devices for body composition, blood pressure, overnight recovery, and glucose response — yours from the Metabolic Rebuild forward. The data pipeline continues flowing into your clinical record, and your provider continues structured review of your data between visits, with proactive outreach if any trend warrants attention.
Nutrition Prescription
Your protein, carbohydrate, fat, and fiber targets continue to evolve as your physiology does. Every visit recalibrates the prescription against current labs, body composition trends, and how you actually feel. Not a meal plan. A clinical prescription that adjusts as you do.
Exercise, Movement & Recovery
Your prescribed exercise, movement, and HRV-informed intensity guidance continue to evolve with your recovery capacity. Lean mass protection remains the priority, especially as your weight stabilizes. Your provider reviews the prescription at every visit and adjusts what your body now needs.
Medication Management
GLP-1 medications continue with careful titration and a planned taper when the time is right. Bioidentical hormone replacement therapy continues with ongoing prescribing, lab monitoring, and formulation adjustments. Metabolic medications continue with the same clinical rigor. All sourced through the same vetted compounding pharmacy.
Health Literacy
The literacy you built during the Metabolic Rebuild becomes how you live. Reading your own metabolic signals, knowing when to flag a shift, making informed decisions between visits — applied independently and refined through ongoing clinical review. Members retain access to the Metabolic Rebuild course indefinitely, with all future updates, and receive 50% off any new course that interests them.
Clinical Validation
Comprehensive lab reassessment continues — targeted reassessments when the clinical picture warrants in Active Care, annual comprehensive panels in Steady Care. The labs confirm what the data and your daily experience already suggest: that the work is holding, and where adjustment is needed next.
Active Care · $425/monthororSteady Care · $250/month
Your provider determines which tier matches your current clinical picture.
Active Care is for patients whose physiology is still in motion. Your weight is still trending toward goal. Your medications are still being titrated. Your hormonal landscape is still shifting. The biology that drove your original metabolic dysfunction is still active, and the higher-frequency oversight is what protects your progress. Six 30-minute visits per year on a bimonthly cadence.
Steady Care is for patients whose physiology has settled. Your weight is at or near goal and stable. Your metabolic medications require no further titration. Your BHRT dose is established with follow-up labs confirming steady levels. The lighter cadence matches where you are clinically. Three 45-minute visits per year, anchored by an annual comprehensive lab reassessment.
The cadence is a clinical decision, not a preference. Steady Care is for patients whose clinical picture supports it. Patients still in active metabolic motion belong in Active Care — that is where the safety of higher-frequency oversight lives.
A transition guided by your clinical progress
The transition from Active Care to Steady Care is not arbitrary, and it is not on a calendar. It is a clinical decision, and you are part of the conversation.
Your provider recommends the transition when several clinical markers converge: your weight is at or near your clinical goal and has remained stable, your metabolic medications require no further titration, your metabolic markers are trending well, and your BHRT dose is established with follow-up labs confirming your levels are steady.
This transition is designed to feel like exactly what it is: clinical progress. Your physiology has stabilized enough that the cadence can shift while the depth of the relationship stays the same. If your physiology shifts — due to life circumstances, a change in hormonal status, or a need to pivot your medication strategy — stepping back into Active Care is always an option.
Where the relationship begins
If you are reading this page, you are evaluating more than a program — you are evaluating whether this practice can be your long-term metabolic and hormonal medical home. That is exactly the right question to be asking at this stage. The Metabolic Evaluation is where the clinical relationship begins. A Discovery Visit is available as a lower-commitment first conversation if you have questions before the Metabolic Evaluation.
The Metabolic Evaluation
Map your full metabolic and hormonal picture. Leave with clear clinical recommendations — yours to keep, whether or not you continue.
Schedule a Metabolic EvaluationThe Discovery Visit
A brief introductory conversation if you would like to talk first before committing to the evaluation.
Schedule a Discovery Visit